Skip to main content
Erschienen in: European Journal of Pediatrics 7/2009

01.07.2009 | Original Paper

B cell cytopenia in two brothers with hyper-IgD and periodic fever syndrome

Erschienen in: European Journal of Pediatrics | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

We report on two brothers with hyperimmunoglobulinemia D (patient 1: serum immunoglobulin D [IgD] concentration initially 61 IU/ml, later on 340 IU/ml; patient 2: serum IgD concentration 144 IU/ml; normal <100 IU/ml, 97th centile) and periodic fever syndrome (HIDS). Both are compound heterozygous for the mevalonate kinase (MVK) mutations V377I and I268T. They developed significant B cell cytopenia (7%, 129/µl and 11%, 132/µl, respectively; normal ranges 12–22%, 300–500/µl) with hypogammaglobulinemia (IgG 5.48 g/l and IgG 5.22 g/l, respectively; normal range IgG 6–13 g/l). Furthermore, the clinical spectrum shows an interesting atypical autoinflammatory symptomatology. The therapy consisted of prednisone, azathioprine, and intravenous immunoglobulins (IVIG), which results in reduced incidence and severity of febrile attacks. Conclusion: The pathogenesis and clinical presentation of HIDS is still not fully understood and show a great variability. To our knowledge, severe B cell cytopenia in children with HIDS has not been reported before. Furthermore, the therapy of febrile episodes is still performed on an individual basis in affected patients.
Literatur
1.
Zurück zum Zitat Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G et al (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46:1597–1600. doi:10.1093/rheumatology/kem200 CrossRef Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G et al (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46:1597–1600. doi:10.​1093/​rheumatology/​kem200 CrossRef
2.
Zurück zum Zitat Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 63:260–264PubMed Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 63:260–264PubMed
3.
Zurück zum Zitat Cailliez M, Garaix F, Rousset-Rouvière C, Bruno D, Kone-Paut I, Sarles J et al (2006) Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis 29:763. doi:10.1007/s10545-006-0408-7 PubMedCrossRef Cailliez M, Garaix F, Rousset-Rouvière C, Bruno D, Kone-Paut I, Sarles J et al (2006) Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis 29:763. doi:10.​1007/​s10545-006-0408-7 PubMedCrossRef
4.
Zurück zum Zitat Cuisset L, Drenth JP, Simon A, Vincent MF, van der Velde Visser S, van der Meer JW et al (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 9:260–266. doi:10.1038/sj.ejhg.5200614 PubMedCrossRef Cuisset L, Drenth JP, Simon A, Vincent MF, van der Velde Visser S, van der Meer JW et al (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 9:260–266. doi:10.​1038/​sj.​ejhg.​5200614 PubMedCrossRef
6.
Zurück zum Zitat de Dios García-Díaz J, Alvarez-Blanco MJ (2001) Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome. J Rheumatol 28:925–926PubMed de Dios García-Díaz J, Alvarez-Blanco MJ (2001) Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome. J Rheumatol 28:925–926PubMed
10.
11.
Zurück zum Zitat Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 73:133–144. doi:10.1097/00005792-199405000-00002 Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 73:133–144. doi:10.​1097/​00005792-199405000-00002
12.
Zurück zum Zitat Drenth JP, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JW (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 85:3586–3593PubMed Drenth JP, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JW (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 85:3586–3593PubMed
13.
Zurück zum Zitat Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG et al (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181. doi:10.1038/9696 PubMedCrossRef Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG et al (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181. doi:10.​1038/​9696 PubMedCrossRef
14.
Zurück zum Zitat Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226PubMed Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226PubMed
15.
Zurück zum Zitat Frenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M et al (2001) Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatology (Oxford) 40:579–584. doi:10.1093/rheumatology/40.5.579 CrossRef Frenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M et al (2001) Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatology (Oxford) 40:579–584. doi:10.​1093/​rheumatology/​40.​5.​579 CrossRef
18.
19.
Zurück zum Zitat Hoffmann G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L (1986) Mevalonic aciduria—an inborn error of cholesterol and nonsterol isoprene biosynthesis. N Engl J Med 314:1610–1614PubMed Hoffmann G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L (1986) Mevalonic aciduria—an inborn error of cholesterol and nonsterol isoprene biosynthesis. N Engl J Med 314:1610–1614PubMed
20.
Zurück zum Zitat Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ et al (1999) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 22:175–177. doi:10.1038/9691 PubMedCrossRef Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ et al (1999) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 22:175–177. doi:10.​1038/​9691 PubMedCrossRef
21.
Zurück zum Zitat Houten SM, van Woerden CS, Wijburg FA, Wanders RJ, Waterham HR (2003) Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet 11:196–200. doi:10.1038/sj.ejhg.5200933 PubMedCrossRef Houten SM, van Woerden CS, Wijburg FA, Wanders RJ, Waterham HR (2003) Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet 11:196–200. doi:10.​1038/​sj.​ejhg.​5200933 PubMedCrossRef
24.
Zurück zum Zitat Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I et al (2008) The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 29:803–808. doi:10.1002/humu.20720 PubMedCrossRef Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I et al (2008) The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 29:803–808. doi:10.​1002/​humu.​20720 PubMedCrossRef
25.
Zurück zum Zitat Naruto T (2007) MVK gene abnormality and new approach to treatment of hyper IgD syndrome and periodic fever syndrome. Nihon Rinsho Meneki Gakkai Kaishi 30:86–89. doi:10.2177/jsci.30.86 PubMed Naruto T (2007) MVK gene abnormality and new approach to treatment of hyper IgD syndrome and periodic fever syndrome. Nihon Rinsho Meneki Gakkai Kaishi 30:86–89. doi:10.​2177/​jsci.​30.​86 PubMed
26.
27.
29.
Zurück zum Zitat van der Hilst JC, Drenth JP, Bodar EJ, Bijzet J, van der Meer JW, Simon A; International HIDS Study Group (2005) Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid 12:115–119. doi:10.1080/13506120500106982 PubMedCrossRef van der Hilst JC, Drenth JP, Bodar EJ, Bijzet J, van der Meer JW, Simon A; International HIDS Study Group (2005) Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid 12:115–119. doi:10.​1080/​1350612050010698​2 PubMedCrossRef
31.
Metadaten
Titel
B cell cytopenia in two brothers with hyper-IgD and periodic fever syndrome
Publikationsdatum
01.07.2009
Erschienen in
European Journal of Pediatrics / Ausgabe 7/2009
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-008-0843-6

Weitere Artikel der Ausgabe 7/2009

European Journal of Pediatrics 7/2009 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.